Fig 1.
Care pathway for adults with obesity in the Lifestyle Medicine clinic.
Referral from primary health care or hospital is followed by eligibility screening, registration, nurse assessment, dietitian pre-visit counseling, and physician evaluation. At the decision point, patients continue follow-up at the Lifestyle Medicine Clinic or are referred to other clinics or hospitals as appropriate.
Table 1.
Baseline Characteristics After Propensity Score Matching (Core variables).
Table 2.
Comparison of clinical outcomes between Liraglutide and non-Liraglutide, after propensity score matching.
Fig 2.
Box Plot of waist circumference at baseline and follow-up in Liraglutide and non-Liraglutide.
The box plot illustrates waist circumference measurements at baseline and follow-up for each group. Within-group changes were analyzed using the Wilcoxon test, showing no significant difference in the non-Liraglutide group (P = 0.432) and the Liraglutide group (P = 0.758). Between-group comparison at follow-up using ANOVA revealed a statistically significant difference (P = 0.03).